Cost-effectiveness analysis of aflibercept in combination with FOLFIRI in the treatment of patients with metastatic colorectal cancer

Cost-effectiveness analysis of aflibercept in combination with FOLFIRI in the treatment of patients with metastatic colorectal cancer

Objectives: To estimate the incremental cost per life-year gained (LYG) of aflibercept in combination with FOLFIRI as second-line treatment in metastatic colorectal cancer (mCRC) patients previously treated with oxaliplatin. Methods: Based on clinical trial VELOUR results, a three-state Markov model...

Full description

Saved in:
Bibliographic Details
Main Authors: M.ª Echave (Author), C. Pericay (Author), C. Frías (Author), A. Abad (Author), M.ª J. Lamas (Author), I. Oyagüez (Author), M. Rubio (Author), E. Giménez (Author), S. Naoshy (Author), F. Joulain (Author)
Format: Book
Published: Elsevier, 2014-07-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items